Single-Dose Studies of a Slow-Release Preparation of Levodopa and Benserazide (Madopar HBS) in Parkinson’s Disease

1987 ◽  
Vol 27 (1) ◽  
pp. 54-58 ◽  
Author(s):  
M.H. Marion ◽  
F. Stocchi ◽  
S.L. Malcolm ◽  
N.P. Quinn ◽  
P. Jenner ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Single Dose ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Ventolin spandets (salbutamol)

1972 ◽  
Vol 10 (24) ◽  
pp. 94-95
Keyword(s):  
Single Dose ◽  
Slow Release ◽  
Salbutamol Sulphate ◽  
Release Preparation ◽  
Adrenergic Activity ◽  
Daily Dose ◽  
Slow Release Preparation

Salbutamol (Ventolin - A & H) is a sympathomimetic agent with mainly (β-adrenergic activity widely used as a bronchodilator. Ventolin Spandet has now been introduced as a slow-release preparation of oral salbutamol. The manufacturers make the specific claim that a single dose gives ‘predictable sustained relief of symptoms for up to 12 hours’, and recommend a daily dose of one. Spandet (salbutamol sulphate 8 mg) at bedtime and one after breakfast.

A single dose bioavailability study on three test-batches of a carbamaz-epine slow release preparation in healthy subjects

1990 ◽  
Vol 183 (2) ◽  
pp. 389-390
Author(s):  
H.-U. Schulz ◽  
R.H. Düsing ◽  
B. Lührmann ◽  
H.-J. Frercks ◽  
F. Krahn ◽  
...  
Keyword(s):  
Single Dose ◽  
Healthy Subjects ◽  
Slow Release ◽  
Release Preparation ◽  
Bioavailability Study ◽  
Slow Release Preparation

Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months

Tubercle ◽  
1976 ◽  
Vol 57 (2) ◽  
pp. 123-130 ◽  
Author(s):  
T. Santha ◽  
Wallace Fox ◽  
O. Nazareth ◽  
R. Prabhakar ◽  
S. Radhakrishna ◽  
...  
Keyword(s):  
Adverse Reactions ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Postscript: beta-blockers - the choice 1980, p 61 and 1981, p 20

1981 ◽  
Vol 19 (9) ◽  
pp. 36.2-36
Keyword(s):  
Slow Release ◽  
Beta Blockers ◽  
200Mg Tablet ◽  
Release Preparation ◽  
Slow Release Preparation

Metoprolol - A second slow-release preparation of metoprolol, Slow Lopresor (Geigy) has just been marketed. We had cited a study which indicated to us that one 200mg tablet of Slow Lopresor did not adequately block β-receptors for 24 hours (MJ Kendall et al, Eur J Clin Pharmacol 1980; 17: 87). The manufacturer has now shown us more recent evidence that one such tablet maintains some measurable β blockade over 24 hours, and is comparable with Betaloc SA.

scholarly journals 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans

1982 ◽  
Vol 83 (5) ◽  
pp. 1062-1070 ◽  
Author(s):  
S.N. Rasmussen ◽  
S. Bondesen ◽  
E.F. Hvidberg ◽  
S. Honoré Hansen ◽  
Vibeke Binder ◽  
...  
Keyword(s):  
Plasma Level ◽  
Slow Release ◽  
Aminosalicylic Acid ◽  
Release Preparation ◽  
Slow Release Preparation

scholarly journals Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease

2019 ◽  
Vol 7 (2) ◽  
pp. e00470 ◽  
Author(s):  
Fernando L. Pagan ◽  
Michaeline L. Hebron ◽  
Barbara Wilmarth ◽  
Yasar Torres‐Yaghi ◽  
Abigail Lawler ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Single Dose ◽  
Pharmacokinetics And Pharmacodynamics

Rectal bioavailability of lidocaine from a suppository and a slow release preparation in man

1979 ◽  
Vol 1 (1) ◽  
pp. 944-950 ◽  
Author(s):  
A. G. De Boer ◽  
D. D. Breimer ◽  
H. Mattie
Keyword(s):  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation
Sign in / Sign up

Export Citation Format

Share Document